B. Braun Canada Launches Introcan Safety® 2 IV Catheter with Multi-Access Blood Control Designed to Protect Clinicians Every Time the Hub is Accessed

MISSISSAUGA, ON – B. Braun Canada Ltd. (B. Braun), a leader in smart infusion therapy, announced today the launch of its new Introcan Safety® 2 IV Catheter with Multi-Access Blood Control. The Introcan Safety 2 IV Catheter is the latest development from B. Braun in a long line of passive needlestick prevention catheters. In addition to automatic needlestick protection, clinicians are protected from blood exposure by a blood control feature every time the hub is accessed1 – reducing the risk of bloodborne pathogen exposure throughout the IV process.

IV access is a critical element of infusion therapy, and needlestick injuries continue to be a serious risk faced by clinicians in their daily routines, potentially exposing them to bloodborne pathogens.2 Studies show that passive, fully automatic safety devices prevent needlestick injuries two times better than a semi-automatic “push button” safety shield and three times better than a manually sliding shield.3 With the Introcan Safety 2 Catheter, clinicians are protected by a truly automatic passive safety device.

In addition to needlestick injuries, mucocutaneous blood exposure due to blood spillage from the catheter hub is also a concern. Blood control IV catheters have been shown to significantly reduce the risk of blood exposure and the workload associated with cleaning.5 In addition, results of a survey point to a potential reduction of costs associated with blood cleanup time and materials.4 With the new Introcan Safety 2 Catheter, the multi-access blood control feature works multiple times, helping to reduce blood exposure and spillage throughout the IV process.

“We’re excited to launch Introcan Safety 2 Multi-Access Blood Control in the Canadian market”, said Bob Comer, President. “I truly believe that this catheter rounds out B. Braun’s peripheral IV catheter product family. We are now able to offer a hospital one family of IV catheters that can meet their entire IV access needs. When combined with our securement device, Clik-FIX®, our technology and solutions are designed to preserve IV access for the duration of treatment.”

For more information on our portfolio of products that seamlessly work to help advance patient and clinician safety and care success, visit

About B. Braun 

B. Braun Canada Ltd. (B. Braun) is a leader in smart infusion therapy and safe and effective pharmacy products, patient and provider safety, and sustainable health solutions. Our purpose is to help providers constantly improve patient satisfaction and outcomes. With products and services created to help healthcare professionals focus on what matters most—their patients—we’re uniquely positioned to help health systems succeed now and in the future. B. Braun is headquartered in Mississauga, Ontario and is part of the B. Braun Group of Companies in North America which includes B. Braun Medical Inc., B. Braun Interventional Systems, Aesculap® and CAPS®. The company employs 8,500 people at over 30 locations across North America.

Globally, the B. Braun Group of Companies employs more than 64,000 employees in 64 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners, and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Canada, explore our website.


1. B. Braun Data on File.

2. Centers for Disease Control and Prevention. Sharps Safety for Healthcare Settings. Available at Last accessed November 3, 2020.

3. Tosini, et al “Needlestick Injury Rates According to Different Types of Safety-Engineered Devices: Results of a French Multicenter Study“, Infection Control and Hospital Epidemiology, Vol 31, No. 4, April 2010 (p. 402-407).

4. Richardson D, “Reducing blood exposure risks and costs associated with SPIVC insertion”, Nursing Management, vol. 42, no. 12, Dec 2011 (reprint p. 31-34).

5. Haesler G. Hildebrand M. Fritscher J. Efficacy and base of use of an intravenous catheter designed to prevent blood leakage: a prospective observational trial. 2015. J Vasc Access: 1-4.